The Prevalence of Malignant Tumors of the Eye and Adnexa (C69)

Malignant tumors of the eye and its adnexa (C69) relates to rare tumors. Until 2011, this group of tumors was not included to the official cancer report in Russia.

Purpose: to investigate the incidence of malignant tumors of eye and its adnexa (C69) in the population of St. Petersburg, to consider the dynamics of a complex of analytical indicators. Standard methods of statistical analysis, state reporting materials and data from the St. Petersburg Population Cancer Register were used. Malignant tumors of the eye and its adnexa (С69) were started to be officially registered only from 2011 onwards, however not in full as only Form 7 that allows to calculate morbidity was filled in. Other information could be obtained from the databases of the Population Cancer Registers (PRR), organized in the country in the late 90’s. Each year, more than 1,000 thousand (e.g.1977–2017 year) cases of malignant tumors of eye and its adnexa (С69) are detected in the whole country. In 2011, 925 cases were diagnosed. In Russia, the crude rate of malignant tumors of the eye and its adnexa (С69) has increased from 2011 to 2017 years from 0.65/100,000 in 2011 to 0.73/100,000 in 2017, respectively, +12.3 % (both sexes), standardized, eliminating the difference in the age composition of the population, remained almost unchanged –0.54 0/0000 and 0.53 0/0000. The standardized incidence rate in men of malignant tumors of eye and its adnexa (С69) in 2017 was 0.58 0/0000, women –0.49 0/0000. The state reporting for malignant tumors of eye and its adnexa (С69) does not provide for the distribution of these patients by age, stage and other parameters. State mortality statistics do not provide for the review of the C-69 heading ICD-10. All of this led us to conduct in-depth analysis of the dynamics of morbidity and mortality of eye cancer on the basis of the PRR database of SaintPetersburg. An insignificant increase in the incidence rate of the Russian population of the eye cancer, completely associated with the aging of the population, has been established. Positive increase in the observed and relative survival of patients has been also revealed. 

1. Forman D., Bray F., Brewster D.H., Gombe Mbalawa C., Kohler B., Piñeros M., et al., editors. Cancer incidence in five continents. Vol. Х. IARC Scientific Publication № 164. Lyon: International Agency for Research of Cancer; 2014: 1365.

2. Chissov V.I., Starinskii V.V., Petrova G.V., editors. Malignant tumors in Russia in 2011 (morbidity and mortality). Moscow: FGBU “MNIOI im. P.A. Gertsena” Minzdrava Rossii; 2013: 289. (In Russ.).

3. Kaprin A.D., Starinskii V.V., Petrova G.V., editors. Malignant tumors in Russia in 2012 (morbidity and mortality). Moscow: FGBU “MNIOI im. P.A. Gertsena” Minzdrava Rossii; 2014: 250. (In Russ.).

4. Kaprin A.D., Starinskii V.V., Petrova G.V., editors. Malignant tumors in Russia in 2013 (morbidity and mortality). Moscow: MNIOI im. P.A. Gertsena, filial FGBU “FMITs im. P.A. Gertsena”; 2015: 250. (In Russ.).

5. Kaprin A.D., Starinskii V.V., Petrova G.V., editors. Malignant tumors in Russia in 2014 (morbidity and mortality). Moscow: MNIOI im. P.A. Gertsena, filial FGBU “FMITs im. P.A. Gertsena”; 2016: 250. (In Russ.).

6. Kaprin A.D., Starinskii V.V., Petrova G.V., editors. Malignant tumors in Russia in 2015 (morbidity and mortality). Moscow: MNIOI im. P.A. Gertsena, filial FGBU “NMIRTs” Minzdrava Rossii; 2017: 250. (In Russ.).

7. Kaprin A.D., Starinskii V.V., Petrova G.V., editors. Malignant tumors in Russia in 2016 (morbidity and mortality). Moscow: MNIOI im. P.A. Gertsena, filial FGBU “NMITs radiologii” Minzdrava Rossii; 2018: 250. (In Russ.).

8. Kaprin A.D., Starinskii V.V., Petrova G.V., editors. Malignant tumors in Russia in 2017 (morbidity and mortality). Moscow: MNIOI im. P.A. Gertsena, filial FGBU “NMITs radiologii” Minzdrava Rossii; 2018: 250. (In Russ.).

9. Merabishvili V.M. Cancer in the North-West Federal Region of Russia (morbidity, mortality, prevalence rate, survival). Express-information. First Issue. St.-Petersburg: Ladoga; 2014: 138. (In Russ.).

10. Merabishvili V.M. Malignant tumors in the North-West Federal Region of Russia (morbidity, mortality, prevalence rate, survival). Express-information. Third Issue. Belyaev AM., editor. St.-Petersburg: T8. Izdatel’skie tekhnologii; 2017: 282. (In Russ.).

11. Merabishvili V.M. Malignant tumors in the North-West Federal Region of Russia (morbidity, mortality, prevalence rate, survival). Express-information. Fourth Issue. Belyaev AM., editor. St.-Petersburg: T8. Izdatel’skie tekhnologii, Kniga po trebovaniyu; 2018: 444. (In Russ.).

12. Merabishvili V.M., Merabishvili E.N. Malignant tumors of the eye and adnexa, morbidity, mortality (population-based study). Ophthalmology in Russia = Oftal’mologiya. 2012;3:71–76 (In Russ.).

13. Merabishvili V.M. Survival of cancer patients. St.Petersburg: Ltd “Firma KOSTA”; 2006: 440. (In Russ.).

14. Merabishvili V.M. Survival of cancer patients. Second Issue. Part 1. Shcherbuk Yu.A, editor. St.-Petersburg: Ltd “Izdatel’sko-poligraficheskaya kompaniya “KOSTA”; 2011: 332. (In Russ.).